[1]KONTUREK P C,BAZELA K,KUKHARSKYY V,et al.Helicobacter pylori upregulates prion protein expression in gastric mucosa:a possible link to prion disease [J].World J Gastroenterol,2005,11(48):7651-7656.
[2]SAFAR J,ROLLER P P,GAJDUSEK D C,et al.Conformational transitions,dissociation,and unfolding of scrapie amyloid (prion) protein [J]. J Biol Chem,1993,268(27):20276-20284.
[3]LE Y,YAZAWA H,GONG W,et al.Cutting edge:The neurotoxic prion peptide fragment PrP106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1 [J].J Immunol,2001,166(3):1448-1451.
[4]HUANG H C,JIANG Z F.Accumulated amyloid-beta peptide and hyperphosphorylated tau protein:relationship and links in Alzheimer’s disease [J]. J Alzheimers Dis,2009,16 (1):15-27.
[5]ANDREASEN N,BLENNOW K.CSF biomarkers for mild cognitive impairment and early Alzheimer’s disease [J]. Clin Neurol Neurosurg,2005,107(3):165-173.
[6]ARISPE N,DOH M.Plasma membrane cholesterol controls the cytotoxicity of Alzheimer’s disease Aβ(1-40) and (1-42) peptides [J].FASEB J,2002,16(12):1526-1536.
[7]CHROMY B A,NOWAK R J,LAMBERT M P,et al.Self-assembly of Abeta(1-42) into globular neurotoxins [J].Biochemistry,2003,42(44):12749-12760.
[8]POWERS J M,LIU Y,HAIR L S,et al.Concomitant Creutzfeldt-Jakob and Alzheimer diseases [J].Acta Neuropathol,1991,83(1):95-98.
[9]HAINFELLNER J A,WANSCHITZ J,JELLINGER K,et al.Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease [J].Acta Neuropathol,1998,96(2):116-122.
[10]VOIGTLÄNDER T,KLÖPPEL S,BIRNER P,et al.Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases [J].Acta Neuropathol,2001,101(5):417-423.
[11]CISSE M,MUCKE L.Alzheimer’s disease:A prion protein connection [J].Nature,2009,457 (7233):1090-1091.
[12]VEERHUIS R,BOSHUIZEN R S,FAMILIAN A.Amyloid associated proteins in Alzheimer's and prion disease [J].Curr Drug Targets CNS Neurol Disord,2005,4(3):235-248.
[13]LAURÉN J,GIMBEL D A,NYGAARD H B,et al.Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers [J].Nature,2009,457 (7233):1128-1132.
[14]TSUCHIYA K,YAGISHITA S,IKEDA K,et al.Coexistence of CJD and Alzheimer's disease:An autopsy case showing typical clinical features of CJD [J].Neuropathology,2004,24(1):46-55.
[15]FERRER I,BLANCO R,CARMONA M,et al.Prion protein expression in senile plaques in Alzheimer’s disease [J].Acta Neuropathol,2001,101 (1):49-56.
[16]BLASI E,BARLUZZI R,BOCCHINI V,et al.Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus [J].J Neuroimmunol,1990,27(2-3):229-237.
[17]PRAT E,BARON P,MEDA L,et al.The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with β-amyloid protein [J].Neurosci Lett,2000,283(3):177-180.
[18]CIESIELSKI-TRESKA J,GRANT N J,ULRICH G,et al.Fibrillar prion peptide (106-126) and scrapie prion protein hamper phagocytosis in microglia [J].Glia,2004,46(2):101-115.
[19]ROTA E,BELLONE G,ROCCA P,et al.Increased intrathecal TGF-β1,but not IL-12,IFN-γ and IL-10 levels in Alzheimer’s disease patients [J].Neurol Sci,2006,27(1):33-39.
[20]STINE W B Jr,DAHLGREN K N,KRAFFT G A,et al.In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis [J].J Biol Chem,2003,278(13):11612-11622.
[21]BAMBERGER M E,HARRIS M E,MCDONALD D R,et al.A cell surface receptor complex for fibrillar β-amyloid mediates microglial activation [J].J Neurosci,2003,23(7):2665-2674.
[22]BURDICK D,SOREGHAN B,KWON M,et al.Assembly and aggregation properties of synthetic Alzheimer’s A4/β amyloid peptide analogs [J].J Biol Chem,1992,267(1):546-554.
[23]DUNZENDORFER S,KASER A,MEIERHOFER C,et al.Dendritic cell migration in different micropore filter assays [J].Immunol Lett,2000,71(1):5-11.
[24]KANEIDER N C,KASER A,DUNZENDORFER S,et al.Sphingosine kinase-dependent migration of immature dendritic cells in response to neurotoxic prion protein fragment [J].J Virol,2003,77(9):5535-5539.
[25]KALLITHRAKA S,BAKKER J,CLIFFORD M N,et al.Correlations between saliva protein composition and some T-I parameters of astringency [J]. Food Qual Prefer,2001,12(2):145-152.
[26]YANG L F,ZHOU X M,YANG J M,et al.Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro [J].J Neuroimmunol,2008,199(1-2):10-17.
[27]BRANDENBURG L O,LUCIUS R,TAMEH ABOLFAZL A,et al.Internalization and signal transduction of PrP106-126 in neuronal cells [J].Ann Anat,2009,191 (5):459-468.
[28]BATE C,VEERHUIS R,EIKELENBOOM P,et al.Microglia kill amyloid-β1-42 damaged neurons by a CD14-dependent process [J].Neuroreport,2004,15(9):1427-1430.
[29]WANG Z F,WEI Z L,LI X M,et al.P1-241 Aβ1-42 can kill murine N2A neuroblastoma cells at nanomolar concentration [J].Neurobiol Aging,2004,25(S2):S165-S171.
[30]SUN Y X,CRISBY M,LINDGREN S,et al.Pravastatin inhibits pro-inflammatory effects of Alzheimer’s peptide Aβ1-42 in glioma cell culture in vitro [J].Pharmacol Res,2003,47(2):119-126.
[31]KREUTZBERG G W.Microglia:a sensor for pathological events in the CNS [J].Trends Neurosci,1996,19(8):312-318.